Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments utilizing Dynamic Pressure Sensing™ (DPS) technology, today highlighted the continued ...
Researchers at Tokushima University have demonstrated single-channel wireless transmission at 112 Gbps in the 560 GHz band ...
Researchers have developed a soft contact lens embedded with electrical stimulation electrodes that, in a mouse model of ...
Do you ever freeze the moment everyone's eyes are on you? Your heart races, your mind goes blank, and suddenly, every word ...
A collaborative research team from Kanazawa University and Kyoto University reports the successful visualization of how densely assembled macrocyclic host molecules cooperatively capture guest ...
A Bayesian particle Gibbs framework enables unbiased spike time inference with millisecond resolution and jointly estimates uncertainties in both spike timing and model parameters from fast calcium ...
Aphios Corporation today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of ...
Simulating the nonlinear optical physics that underlies ultrafast laser systems is computationally demanding—a practical bottleneck in settings that require rapid feedback. A study by researchers at ...
Researchers demonstrated an on-chip method for optically pumping InP nanowire emitters using transfer-printed micro-LEDs, ...
A team of researchers at the National Institutes of Health (NIH) have unveiled new details about the events GLP-1 receptor ...
The Switzerland Eye Research Institute (SERI Lugano), based in Lugano, Switzerland, is an independent research and clinical ...
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results